Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Study Comparing the Diagnostic Yield and Specimen Adequacy of Flex 19 G EBUS-TBNA Needles and 22 G EBUS-FNB Device for the Evaluation of Mediastinal and Hilar Lymphadenopathy

NCT05535439 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT05535439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05535439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Study Comparing the Diagnostic Yield and Specimen Adequacy of Flex 19 G EBUS-TBNA Needles and 22 G EBUS-FNB Device for the Evaluation of Mediastinal and Hilar Lymphadenopathy
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2022
Completion date
August 31, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hilar lymphadenopathy, mediastinal lymphadenopathy